| Sep 10 |
Verona Pharma: A Post FDA Approval Analysis
|
| Sep 5 |
Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024
|
| Aug 15 |
Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)
|
| Aug 14 |
Top 3 Health Care Stocks That May Crash In August
|
| Aug 9 |
Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?
|
| Aug 8 |
Verona Pharma plc (VRNA) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Verona Pharma GAAP EPS of -$0.11 beats by $0.10
|
| Aug 8 |
Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 7 |
Verona Pharma Q2 2024 Earnings Preview
|
| Aug 3 |
Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability
|
